Author:
McCoy Clare F.,Spence Patrick,Dallal Bashi Yahya H.,Murphy Diarmaid J.,Boyd Peter,Dangi Bindi,Derrick Tiffany,Devlin Bríd,Kleinbeck Kyle,Malcolm R. Karl
Reference87 articles.
1. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives;Abdel-Aleem,2013
2. S.L. Achilles, C.W. Hendrix, S.M. Poloyac, C.J. Hoesley, M. Peda, H. Gundacker, et al., Safety and pharmacokinetics of dapivirine and levonorgestrel vaginal rings for multipurpose prevention of HIV and pregnancy, AIDS Res. Hum. Retrovir. 34 (2018) 46 (Abstract OA12.02LB).
3. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg);Algorta;Eur J Contracept Reprod Health Care,2017
4. Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials;Archer;Lancet Glob. Health,2019
5. Pessary Use and Management for Pelvic Organ Prolapse;Atnip;Obstet. Gynecol. Clin. N. Am.,2009
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献